230 related articles for article (PubMed ID: 31563545)
1. Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience.
Franceschini D; De Rose F; Cozzi S; Renna I; Franzese C; Di Brina L; Navarria P; D'Agostino GR; Mancosu P; Tomatis S; Scorsetti M
Clin Lung Cancer; 2020 Jan; 21(1):86-93. PubMed ID: 31563545
[TBL] [Abstract][Full Text] [Related]
2. Locoregional control and toxicity after pleurectomy/decortication and intensity-modulated pleural radiation therapy in patients with malignant pleural mesothelioma.
Arrieta O; Lozano-Ruiz F; Blake-Cerda M; Catalán R; Lara-Mejía L; Salinas MÁ; Maldonado-Magos F; Corona-Cruz JF
Thorac Cancer; 2020 Dec; 11(12):3448-3455. PubMed ID: 33030313
[TBL] [Abstract][Full Text] [Related]
3. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
[TBL] [Abstract][Full Text] [Related]
4. Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.
Minatel E; Trovo M; Bearz A; Di Maso M; Baresic T; Drigo A; Barresi L; Furlan C; Del Conte A; Bruschi G; Fontana P; Pagan V; Franchin G
Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):606-13. PubMed ID: 26281826
[TBL] [Abstract][Full Text] [Related]
5. High dose irradiation after pleurectomy/decortication or biopsy for pleural mesothelioma treatment.
Parisi E; Romeo A; Sarnelli A; Ghigi G; Bellia SR; Neri E; Micheletti S; Dipalma B; Arpa D; Furini G; Burgio MA; Genestreti G; Gurioli C; Sanna S; Bovolato P; Rea F; Storme G; Scarpi E; Arienti C; Tesei A; Polico R
Cancer Radiother; 2017 Dec; 21(8):766-773. PubMed ID: 29132803
[TBL] [Abstract][Full Text] [Related]
6. Radical Hemithoracic Radiotherapy Versus Palliative Radiotherapy in Non-metastatic Malignant Pleural Mesothelioma: Results from a Phase 3 Randomized Clinical Trial.
Trovo M; Relevant A; Polesel J; Muraro E; Barresi L; Drigo A; Baresic T; Bearz A; Fanetti G; Del Conte A; Matrone F; Reverberi C; Furlan C; Zuccon U; Fontana P; Franchin G; Minatel E
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1368-1376. PubMed ID: 33259933
[TBL] [Abstract][Full Text] [Related]
7. Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy.
Kimura T; Doi Y; Nakashima T; Imano N; Katsuta T; Takahashi S; Kenjo M; Ozawa S; Murakami Y; Nagata Y
J Radiat Res; 2015 Mar; 56(2):315-24. PubMed ID: 25599996
[TBL] [Abstract][Full Text] [Related]
8. Phase II Study of Hemithoracic Intensity-Modulated Pleural Radiation Therapy (IMPRINT) As Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma.
Rimner A; Zauderer MG; Gomez DR; Adusumilli PS; Parhar PK; Wu AJ; Woo KM; Shen R; Ginsberg MS; Yorke ED; Rice DC; Tsao AS; Rosenzweig KE; Rusch VW; Krug LM
J Clin Oncol; 2016 Aug; 34(23):2761-8. PubMed ID: 27325859
[TBL] [Abstract][Full Text] [Related]
9. Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma.
Rimner A; Spratt DE; Zauderer MG; Rosenzweig KE; Wu AJ; Foster A; Yorke ED; Adusumilli P; Rusch VW; Krug LM
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):394-401. PubMed ID: 25073664
[TBL] [Abstract][Full Text] [Related]
10. Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
Yorke ED; Jackson A; Kuo LC; Ojo A; Panchoo K; Adusumilli P; Zauderer MG; Rusch VW; Shepherd A; Rimner A
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):61-69. PubMed ID: 28816162
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric Correlates of Pulmonary Toxicity in Patients with Malignant Pleural Mesothelioma Receiving Radiation Therapy to the Intact Lungs.
Thompson MR; Dumane VA; Lazarev SA; Zia Y; Rosenzweig KE
Pract Radiat Oncol; 2019 May; 9(3):e331-e337. PubMed ID: 30654090
[TBL] [Abstract][Full Text] [Related]
12. Disease-Related Outcomes and Toxicities of Intensity Modulated Radiation Therapy After Lung-Sparing Pleurectomy for Malignant Pleural Mesothelioma: A Systematic Review.
Patel R; Ludmir EB; Miccio JA; Menon H; Barsky AR; Mesko SM; Kodali M; Lautenschlaeger T; Adeberg S; Simone CB; Verma V
Pract Radiat Oncol; 2020; 10(6):423-433. PubMed ID: 32088429
[TBL] [Abstract][Full Text] [Related]
13. Tomotherapy improves local control and changes failure patterns in locally advanced malignant pleural mesothelioma.
Kishan AU; Cameron RB; Wang PC; Alexander S; Qi SX; Low DA; Kupelian PA; Steinberg ML; Lee JM; Selch MT; Lee P
Pract Radiat Oncol; 2015; 5(6):366-73. PubMed ID: 26432677
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy for Malignant Pleural Mesothelioma.
Rosenzweig KE
Thorac Surg Clin; 2020 Nov; 30(4):473-480. PubMed ID: 33012434
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiotherapy and volumetric-modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy.
Krayenbuehl J; Riesterer O; Graydon S; Dimmerling P; Kloeck S; Ciernik IF
J Appl Clin Med Phys; 2013 Jul; 14(4):4130. PubMed ID: 23835378
[TBL] [Abstract][Full Text] [Related]
16. Extra-pleural pneumonectomy in the era of image-guided intensity-modulated radiotherapy.
Trovo M; Franceschini D; Furlan C; Pietrobon F; Vagge S; Farina E; Revelant A; Visani L; Maragna V; Parisi G; Scotti V
Radiol Med; 2019 Sep; 124(9):854-859. PubMed ID: 30963379
[TBL] [Abstract][Full Text] [Related]
17. [Value of tomotherapy in malignant pleural mesothelioma: first clinical results].
Giraud P; Sylvestre A; Lisbona A; Zefkili S; Bonnette P; Le Pimpec Barthes F; Michaud JL; Perigaud C; Mahé MA
Rev Mal Respir; 2011 May; 28(5):609-17. PubMed ID: 21645831
[TBL] [Abstract][Full Text] [Related]
18. Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.
Minatel E; Trovo M; Polesel J; Rumeileh IA; Baresic T; Bearz A; Del Conte A; Franchin G; Gobitti C; Drigo A; Dassie A; Pagan V; Trovo MG
J Thorac Oncol; 2012 Dec; 7(12):1862-1866. PubMed ID: 23154558
[TBL] [Abstract][Full Text] [Related]
19. Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma.
Rosenzweig KE; Zauderer MG; Laser B; Krug LM; Yorke E; Sima CS; Rimner A; Flores R; Rusch V
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1278-83. PubMed ID: 22607910
[TBL] [Abstract][Full Text] [Related]
20. Hemithoracic intensity modulated radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a matched survival analysis.
Chance WW; Rice DC; Allen PK; Tsao AS; Fontanilla HP; Liao Z; Chang JY; Tang C; Pan HY; Welsh JW; Mehran RJ; Gomez DR
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):149-56. PubMed ID: 25442335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
